THNK:CC - Think Research Announces Grant of Equity Compensation

Canada NewsWire

TORONTO , June 10, 2022 /CNW/ - Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) (" Think " or the " Company "), a company focused on transforming healthcare through integrated digital health software solutions, today announced that it has granted 1,220,000 restricted share units (each, an " RSU ") to key employees of the Company pursuant to the Company's Omnibus Equity Incentive Plan which vest as follow: ? vest on December 31, 2022 ; ? vest on December 31, 2023 , and; ? vest on December 31, 2024 . In addition, the Company has granted 255,716 RSUs to key employees of the Company pursuant to the Company's Omnibus Equity Incentive Plan which vest immediately upon grant.

Think also announced that it has granted 166,702 deferred share units (each, a " DSU ") to certain non-executive directors of the Company pursuant to the Company's Omnibus Equity Incentive Plan. Each DSU represents the right to receive one Common Share upon the holder of such DSU ceasing to be employed as an officer, employee or director of the Company or any of its subsidiaries.

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes. For over a decade, Think's cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care – including primary physician care, acute care hospitals and surgical suites as well as community and seniors care. Think is proud to serve as a trusted health system partner to a rapidly growing, global client base that spans five continents across more than 13,000 healthcare facilities, with a clinical audience of over 300,000 doctors, nurses and pharmacists. Visit www.thinkresearch.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibilities for the adequacy or accuracy of this release.

SOURCE Think Research Corporation

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/10/c0324.html